NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2025-09-17333,340$15.00
$5.00MBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-1488,794$11.44
$1.02MBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-1314,950$11.63
$173.87kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-128,971$11.86
$106.40kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-119,593$10.95
$105.04kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-10574$10.90
$6.26kBuy

1 of 1

ORKA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter W. Sonsini21.11%10,221,465$307.67MInsider
Krishna Kittu Kolluri21.11%10,221,465$307.67MInsider
Joshua Makower21.11%10,221,465$307.67MInsider
Ravi Viswanathan21.11%10,221,465$307.67MInsider
Anthony A. Florence Jr.21.11%10,221,465$307.67MInsider
Harry R. Weller21.11%10,221,465$307.67MInsider
David M. Mott21.11%10,221,465$307.67MInsider
Forest Baskett21.11%10,221,465$307.67MInsider
Peter J. Barris21.11%10,221,465$307.67MInsider
Jon Sakoda21.11%10,221,465$307.67MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA22.87%77.13%Net BuyingNet Buying
URGN81.41%18.59%Net SellingNet Selling
ARDX41.73%58.27%Net BuyingNet Selling
RAPP75.33%24.67%Net SellingNet Selling
NRIX90.92%9.08%Net SellingNet Selling

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 94.11% institutional shareholders, 317.30% Oruka Therapeutics insiders, and 0.00% retail investors. Peter W. Sonsini is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 21.11% of the company. Peter W. Sonsini's Oruka Therapeutics shares are currently valued at $282.83M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.